This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

New Peer-Reviewed Publication Demonstrates Patient Safety Aspects Of Vision-Sciences' EndoSheath(R) Technology For Flexible Cystoscopes

Stocks in this article: VSCI

ORANGEBURG, N.Y., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the publication of positive outcomes of a clinical study that evaluated the durability and microbial barrier properties of the Company's EndoSheath ® technology in the flexible cystoscopy setting in the November issue of the peer-reviewed journal BMC Urology.

To assess the efficacy of Vision-Sciences' EndoSheath technology with flexible cystoscopes, study authors tested the barrier integrity of each EndoSheath disposable following clinical procedures and then performed microbiology sampling of the flexible cystoscopes to determine if any bacterial contamination had occurred. Study outcomes and conclusions include:

  • 100% of EndoSheath units tested were leak-free following clinical use. This finding confirms outcomes of a prior study of 875 endoscopic procedures in which no leaks were reported.  
  • 100% of microbiology samples showed a clean flexible cystoscope following EndoSheath technology usage and the Company's recommended cleaning procedure.  
  • The study authors concluded that Vision-Sciences' reprocessing procedure featured a low risk of pathogen transmission, high-patient safety and a valid alternative to the recommended high-level disinfection procedure of competitive flexible cystoscopes.

"This was the first research to assess the microbiology and sheath integrity of our EndoSheath technology in the cystoscopy setting. These highly positive results demonstrate that the EndoSheaths did not break, and that the use of our EndoSheath technology followed by our three-step cleaning process has a low risk of pathogen transmission and high patient safety. This supports our longstanding position that the EndoSheath technology provides an 'always ready, always sterile' endoscope," said Howard Zauberman, Vision-Sciences' Interim Chief Executive Officer.

The study, entitled "A microbiological evaluation of level of disinfection for flexible cystoscopes protected by disposable endosheaths," was conducted by researchers in Denmark at the Frederiksberg University Hospital, Hvidovre University Hospital, and University of Copenhagen. Microbiological samples from 100 cystoscopies performed with flexible cystoscopes ("FC") using disposable sterile EndoSheaths were obtained twice: after removal of the EndoSheath, and after cleaning the scope with a detergent cloth, rinsing with tap water followed by 70% ethanol disinfection, and subsequent drying. 

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs